Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
18.04
+0.07 (0.39%)
At close: May 8, 2026
Huaxia Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 462.64 | 440.65 | 428.64 | 665.93 | 513.82 | 454.92 |
Depreciation & Amortization | 322.34 | 322.34 | 309.4 | 274.36 | 274.11 | 265.64 |
Other Amortization | 79.64 | 79.64 | 68.94 | 58.5 | 49.05 | 50.55 |
Loss (Gain) From Sale of Assets | -2.46 | -2.46 | -3.49 | -11.28 | -1.85 | -0.1 |
Asset Writedown & Restructuring Costs | 7.6 | 7.6 | 12.03 | 6.15 | 0.46 | 1.88 |
Loss (Gain) From Sale of Investments | -37.3 | -37.3 | -65.76 | -87.46 | -14.5 | -8.73 |
Provision & Write-off of Bad Debts | 5.08 | 5.08 | 11.86 | 11.31 | 3.5 | 4.36 |
Other Operating Activities | 96.43 | 42.74 | 46.79 | 50.96 | 34.53 | 38.05 |
Change in Accounts Receivable | 19.66 | 19.66 | 330.57 | -61.85 | -69.24 | -12.08 |
Change in Inventory | -7.92 | -7.92 | 56.96 | -33.06 | -31.23 | -18.74 |
Change in Accounts Payable | 18.69 | 18.69 | -363.65 | 108.83 | 4.01 | 12.95 |
Change in Other Net Operating Assets | - | - | - | - | 0.77 | 5.16 |
Operating Cash Flow | 943.26 | 867.58 | 820.3 | 961.24 | 769.98 | 798.02 |
Operating Cash Flow Growth | 8.67% | 5.76% | -14.66% | 24.84% | -3.51% | 35.11% |
Capital Expenditures | -205.53 | -231.99 | -279.59 | -448.43 | -235.31 | -173.63 |
Sale of Property, Plant & Equipment | 3.89 | 3.81 | 2.37 | 1.72 | 3.56 | 1.79 |
Cash Acquisitions | -298.32 | -301.15 | -421.41 | 1.82 | -10.31 | - |
Divestitures | - | - | 1.56 | 28.55 | - | - |
Investment in Securities | -597.53 | -608.06 | -132.84 | 2,247 | -2,795 | -2.02 |
Other Investing Activities | 867.25 | 61.16 | 82.42 | 78.21 | - | 6.11 |
Investing Cash Flow | -230.24 | -1,076 | -747.5 | 1,909 | -3,037 | -167.74 |
Long-Term Debt Issued | - | 60 | - | - | 26.13 | - |
Long-Term Debt Repaid | - | -480.59 | -195.04 | -144.66 | -143.14 | -122.43 |
Net Debt Issued (Repaid) | -450.64 | -420.59 | -195.04 | -144.66 | -117.01 | -122.43 |
Issuance of Common Stock | - | - | - | 2.1 | 3,053 | - |
Repurchase of Common Stock | -1.37 | -1.37 | -199.65 | - | - | - |
Common Dividends Paid | -261.58 | -258.07 | -91.71 | -156.8 | - | -0.16 |
Other Financing Activities | -70.38 | -88.12 | -19.75 | -5.13 | -284.65 | -57.99 |
Financing Cash Flow | -783.98 | -768.15 | -506.15 | -304.49 | 2,651 | -180.58 |
Net Cash Flow | -70.95 | -976.8 | -433.36 | 2,566 | 384.16 | 449.69 |
Free Cash Flow | 737.73 | 635.59 | 540.71 | 512.81 | 534.68 | 624.38 |
Free Cash Flow Growth | 20.48% | 17.55% | 5.44% | -4.09% | -14.37% | 46.11% |
Free Cash Flow Margin | 17.58% | 15.36% | 13.43% | 12.78% | 16.54% | 20.38% |
Free Cash Flow Per Share | 0.88 | 0.76 | 0.64 | 0.61 | 0.70 | 0.83 |
Cash Interest Paid | 2.92 | 2.92 | 0.41 | 0.52 | 0.5 | - |
Cash Income Tax Paid | 227.43 | 226.28 | 258.37 | 200.68 | 170.18 | 173.68 |
Levered Free Cash Flow | 855.03 | 552.62 | 464.23 | 425.75 | 447.72 | 475.76 |
Unlevered Free Cash Flow | 884.23 | 581.97 | 492.43 | 449.53 | 471.7 | 499.27 |
Change in Working Capital | 9.28 | 9.28 | 11.88 | -7.24 | -89.12 | -8.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.